Atlas Trials

Expanded Access to SUVN-G3031 (Samelisant) for the Treatment of Subjects With Narcolepsy

Clinical trial NCT05530447 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT05530447
Sponsor
Suven Life Sciences Limited
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Narcolepsy

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.